A detailed history of Werlinich Asset Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Werlinich Asset Management, LLC holds 90,385 shares of PFE stock, worth $2.54 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares
90,385
Previous 90,160 0.25%
Holding current value
$2.54 Million
Previous $2.51 Billion 4.36%
% of portfolio
1.52%
Previous 1.56%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$27.7 - $31.39 $6,232 - $7,062
225 Added 0.25%
90,385 $2.62 Billion
Q2 2024

Jul 15, 2024

BUY
$25.26 - $29.6 $34,101 - $39,960
1,350 Added 1.52%
90,160 $2.51 Billion
Q1 2024

Apr 11, 2024

BUY
$25.89 - $29.73 $234,641 - $269,442
9,063 Added 11.36%
88,810 $2.47 Billion
Q4 2023

Jan 09, 2024

BUY
$26.13 - $33.94 $57,407 - $74,566
2,197 Added 2.83%
79,747 $2.28 Billion
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $36,903 - $43,136
-1,150 Reduced 1.46%
77,550 $2.57 Billion
Q2 2023

Nov 13, 2023

BUY
$36.12 - $41.79 $68,628 - $79,401
1,900 Added 2.47%
78,700 $2.89 Billion
Q1 2023

Nov 13, 2023

BUY
$39.39 - $51.28 $11,423 - $14,871
290 Added 0.38%
76,800 $3.13 Billion
Q4 2022

Nov 13, 2023

BUY
$41.75 - $54.5 $15,238 - $19,892
365 Added 0.48%
76,510 $3.92 Billion
Q3 2022

Nov 13, 2023

SELL
$43.76 - $53.42 $13,128 - $16,026
-300 Reduced 0.39%
76,145 $3.33 Billion
Q2 2022

Nov 13, 2023

SELL
$46.53 - $55.17 $46,530 - $55,170
-1,000 Reduced 1.29%
76,445 $4.01 Billion
Q1 2022

Nov 13, 2023

BUY
$45.75 - $56.69 $5,032 - $6,235
110 Added 0.14%
77,445 $4.01 Billion
Q3 2021

Nov 13, 2023

SELL
$39.25 - $50.42 $401,920 - $516,300
-10,240 Reduced 11.69%
77,335 $3.33 Billion
Q1 2021

Nov 13, 2023

BUY
$33.49 - $37.77 $2.93 Million - $3.31 Million
87,575 New
87,575 $3.17 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $158B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Werlinich Asset Management, LLC Portfolio

Follow Werlinich Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Werlinich Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Werlinich Asset Management, LLC with notifications on news.